Primary Liver Cancer
41
12
15
10
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.3%
3 terminated out of 41 trials
76.9%
-9.6% vs benchmark
5%
2 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (41)
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
cfDNA Methylation for Liver Cancer Recurrence Detection
Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment
Registry on Percutaneous Electrochemotherapy
Precision Dietary Intervention Improves Postoperative Energy Intake, Nutritional Status, and Recovery in Patients Undergoing Hepatectomy for Liver Cancer: A Randomized Controlled Trial
Y-90 Treatment Response Using Transarterial Radioembolization
An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.
The Dragon PLC Trial (DRAGON-PLC)
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection
Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
Recurrent Liver Cancer: Reconceptualization and Reevaluation
Multi-mode Ablation and Molecular Imaging Multi-omics Study for Digestive-Origin Malignant Liver Tumors
Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer
Liver Embolization Approaches for Tumor Management
Clinical Characteristics of Primary Liver Cancer
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer
TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
MRI-guided Holmium-166 Radioembolization